AI assistant
EXAGEN INC. — Director's Dealing 2024
Feb 22, 2024
33644_dirs_2024-02-22_28e25937-182c-403f-9f5c-cc60bbb64e66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2024-02-20
Reporting Person: ABALLI JOHN (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-20 | Common Stock | A | 175000 | — | Acquired | 590984 | Direct |
Footnotes
F1: Represents 175,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time.